Dova Pharmaceuticals.

PositionDURHAM

Dova Pharmaceuticals raised $75 million in an initial public offering. The company acquires and develops drugs for rare diseases. Its leading product is a treatment for patients with chronic liver disease. Its biggest shareholder is...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT